| ALMIRALL SA | 11.52 / -0.35% |
| Date/Time | 01/25 / 17:26 |
| Chg. / Chg.(%) | -0.04 / -0.35% |
| Bid | - |
| Ask | - |
| Open | 11.63 |
| Previous Close | 11.56 |
| High | 11.71 |
| Low | 11.52 |
| Volume [EUR] | 94,951.34 |
| Volume [Units] | 8,197 |
| Price fixings | 52 |
| ISIN | ES0157097017 |
| Security | ALM/E |
| Exchange | Turquoise |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Madrid | 11.4900 |  |
307,014 |
| Cboe Europe .. | 11.52 | |
51,886 |
| London Inter.. | 11.49 | |
13,600 |
| Turquoise | 11.52 | |
8,197 |
| Frankfurt | 11.6100 | |
0 |
| Berlin | 11.610 | |
0 |
| Stuttgart | 11.570 | |
0 |
| Lang & Schwa.. | 11.460 | |
|
| TradeGate | 11.94 | 237 | |
| Cboe Europe .. | 12.00 | 370 | |
| Cboe Europe .. | 12.01 | 150 | |
| Nasdaq Other.. | 12.4000 | 1,087 |
News
- Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
01/06/2021 / 14:00 - GlobeNewswire - Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group
01/04/2021 / 23:00 - GlobeNewswire - Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
12/15/2020 / 13:00 - GlobeNewswire - Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company Growth
12/08/2020 / 14:13 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
12/01/2020 / 22:05 - GlobeNewswire
Real-time